Since its inception, the Rare Tumor Initiative has made significant strides in advancing research and treatment. Collaborative efforts have led to the discovery of novel genetic mutations and potential therapeutic targets. Clinical trials have been launched to test new treatment modalities, offering hope to patients with limited options. Moreover, the initiative has succeeded in raising awareness and increasing engagement among stakeholders, fostering a community dedicated to combating rare tumors.
